Selected article for: "Antibody engineering and phage display"

Author: Saeed, Abdullah F. U. H.; Wang, Rongzhi; Ling, Sumei; Wang, Shihua
Title: Antibody Engineering for Pursuing a Healthier Future
  • Document date: 2017_3_28
  • ID: 0fegsm1v_4
    Snippet: Antibody production was primarily dependent on animal immunization until the late 1980s by using experimental mice, rabbits and other related laboratory animals (Wang et al., 2010) . The main difficulty in the production and application of monoclonal antibodies is the incompetent immune response to highly toxic or conserved antigens. Furthermore, most clinical antibodies are of human origin or are at least humanized in some aspect to avoid immuno.....
    Document: Antibody production was primarily dependent on animal immunization until the late 1980s by using experimental mice, rabbits and other related laboratory animals (Wang et al., 2010) . The main difficulty in the production and application of monoclonal antibodies is the incompetent immune response to highly toxic or conserved antigens. Furthermore, most clinical antibodies are of human origin or are at least humanized in some aspect to avoid immunogenicity (Reichert, 2013) . Therefore, transgenic mice and rabbits with human antibody genes have been developed to solve this immunogenicity problem but not the necessity of an effective immune response after immunization. Finally, to overcome this problem, human antibodies were generated in vitro by antibody engineering technologies such as phage display, construction of antibody fragments, immunomodulatory antibodies, and cell-free systems (Edwards and He, 2012) .

    Search related documents:
    Co phrase search for related documents
    • animal immunization and Antibody production: 1, 2, 3
    • animal immunization and clinical antibody: 1, 2
    • animal immunization and human antibody: 1, 2, 3, 4, 5
    • animal immunization and immune response: 1, 2, 3
    • antibody fragment and application production: 1
    • antibody fragment and cell free system: 1
    • antibody fragment and human antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antibody fragment and immune response: 1, 2, 3
    • antibody gene and clinical antibody: 1, 2, 3, 4
    • antibody gene and engineering technology: 1
    • antibody gene and human antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • antibody gene and human antibody gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antibody gene and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody gene and immunization immune response: 1
    • Antibody production and engineering technology: 1, 2
    • Antibody production and human antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • Antibody production and human origin: 1
    • Antibody production and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Antibody production and immunization immune response: 1, 2, 3